Sunnybrook Health Sciences Centre ~ News & Media ~ Prostate Cancer Risk Online Tool Supports More Dialogue
![Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3 Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3](https://www.frontiersin.org/files/Articles/908956/fonc-12-908956-HTML/image_m/fonc-12-908956-g001.jpg)
Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
![SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/3aad0880313aaaa98232afa144d67ec911e27a25.gif)
SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection
![SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/4966e23dbbb57e0e806f4c569f2439f76166ebb8.gif)
SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection
![The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer | SpringerLink The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11255-019-02261-8/MediaObjects/11255_2019_2261_Fig1_HTML.png)
The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer | SpringerLink
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/4-Table2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-58836-4/MediaObjects/41598_2020_58836_Fig1_HTML.png)
A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports
![SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and](https://minio.scielo.br/documentstore/1677-6119/5GWVS9m8y55TZvZ89YVmVbz/e3f287786901ff1f9230b1df00909c7c5795c03c.gif)
SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and
Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men | PLOS ONE
![The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/e6efcdbc-0cc7-43ff-844a-0b7a07b15cb9/gr1_lrg.jpg)
The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus
![PSA Screening — Dr James Thompson is an experienced Urological Surgeon specialising in robotic surgery for prostate and bladder cancer PSA Screening — Dr James Thompson is an experienced Urological Surgeon specialising in robotic surgery for prostate and bladder cancer](https://images.squarespace-cdn.com/content/v1/5d09944f1c172000010bf8dd/1568690705667-CW3OJFH7SSPHFS7JYCGK/Untitled-5-01.png)
PSA Screening — Dr James Thompson is an experienced Urological Surgeon specialising in robotic surgery for prostate and bladder cancer
![Table 3 from Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less | Semantic Scholar Table 3 from Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5bbcdc5c6576e0425042645222a1a433570d3e04/3-Table3-1.png)
Table 3 from Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less | Semantic Scholar
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
![Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening | Scientific Reports Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-77668-w/MediaObjects/41598_2020_77668_Fig1_HTML.png)